Results 21 to 30 of about 899,405 (297)

Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study [PDF]

open access: yes, 2019
We assessed the health-related quality of life (HRQoL) in CVID adults receiving different schedules of immunoglobulin replacement therapy (IgRT) by intravenous (IVIG), subcutaneous (SCIG), and facilitated (fSCIG) preparations.
Agostini, Carlo   +13 more
core   +2 more sources

Use of Intravenous Immunoglobulins in Intensive Therapy

open access: yesОбщая реаниматология, 2012
The main cause of death in the intensive care units is infectious complications, including sepsis and septic shock. Immunoglobulins are the most potent mechanisms in anti-infective defense.
E. A. Latysheva, T. V. Latysheva
doaj   +1 more source

Intrathecal cytomegalovirus immunoglobulin for CMV encephalitis post allogeneic stem cell transplantation

open access: yesIDCases, 2022
We report the outcome of a 43 year old man who developed fatal ventriculoencephalitis due to cytomegalovirus (CMV) infection 7 months post allogeneic stem cell transplant.
Ian Pang   +5 more
doaj   +1 more source

Immunoglobulins in neurological practice: a review of the literature

open access: yesНервно-мышечные болезни, 2019
Today intravenous immunoglobulins are used increasingly in the management of patients with neurological conditions. The efficacy and safety of intravenous immunoglobulins treatment in chronic inflammatory demyelinating polyradiculoneuropathy, Guillain ...
S. S. Nikitin, L. M. Boriskina
doaj   +1 more source

Serum levels of matrix metalloproteinases-2 and-9 and their tissue inhibitors in inflammatory neuromuscular disorders [PDF]

open access: yes, 2006
We monitored serum levels of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) before and during intravenously applied immunoglobulin (IVIG) therapy in 33 patients with chronic immune-mediated neuropathies and myopathies and 15 ...
B.G.H. Schoser   +15 more
core   +1 more source

Immunoglobulin: production, mechanisms of action and formulations

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2011
Human immunoglobulin (Ig) began to be applied in the clinical practice with the treatment of primary immunodeficiencies. Quickly, applications of Ig increased, as its anti-inflammatory and immunomodulatory functions were elucidated.
Marcia Cristina Zago Novaretti   +1 more
doaj   +1 more source

Anti-Inflammatory and Immunomodulatory Effect of High-Dose Immunoglobulins in Children: From Approved Indications to Off-Label Use

open access: yesCells, 2023
Background: The large-scale utilization of immunoglobulins in patients with inborn errors of immunity (IEIs) since 1952 prompted the discovery of their key role at high doses as immunomodulatory and anti-inflammatory therapy, in the treatment of IEI ...
Francesca Conti   +14 more
doaj   +1 more source

IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS

open access: yesМедицинская иммунология, 2014
Treatment with intravenous immunoglobulins (IVIG) is widely used in modern clinical practice inorder to cure different clinical disorders, including obstetric conditions. Currently, IVIGs have become drugs of  choice  for  treatment of  anti-phospholipid 
S. A. Sel'kov   +2 more
doaj   +1 more source

Single-domain antibodies and their formatting to combat viral infections [PDF]

open access: yes, 2018
Since their discovery in the 1990s, single-domain antibodies (VHHs), also known as NanobodiesA (R), have changed the landscape of affinity reagents. The outstanding solubility, stability, and specificity of VHHs, as well as their small size, ease of ...
Ballegeer, Marlies   +4 more
core   +2 more sources

Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double‐blind clinical trial

open access: yesAmerican Journal of Transplantation, 2018
There are no approved treatments for chronic antibody mediated rejection (ABMR). We conducted a multicenter, prospective, randomized, placebo‐controlled, double‐blind clinical trial to evaluate efficacy and safety of intravenous immunoglobulins (IVIG ...
F. Moreso   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy